Dmitri V. Lissin
Director Técnico/Científico/I+D en SCILEX HOLDING COMPANY .
Origen de la red de primer grado Dmitri V. Lissin.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Public Company | Pharmaceuticals: Other | 10 | |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Dmitri V. Lissin a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| University of Mumbai | College/University | Graduate Degree Undergraduate Degree | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Founder | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Arizona | College/University | Doctorate Degree Undergraduate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Corporate Officer/Principal Graduate Degree | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| Knoll Pharmaceutical Co. | Director/Board Member | ||
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Director/Board Member | |
| BIOptima Advisors LLC | Founder | ||
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
| Licensing Executives Society | Corporate Officer/Principal | ||
| JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal | |
| ALTIMMUNE, INC. | Biotechnology | Director of Finance/CFO | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Marshall University | College/University | Undergraduate Degree | |
| Isarna Therapeutics, Inc. | Director of Finance/CFO | ||
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Bear Stearns Health Innoventures LP | Investment Managers | Corporate Officer/Principal | |
| The University of Manchester | College/University | Undergraduate Degree | |
| University of Kentucky | College/University | Doctorate Degree | |
| COHBAR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ANEBULO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Estados Unidos | 44 |
| India | 2 |
| China | 2 |
| Francia | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 204 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 60 |
| Chairman | 36 |
| Chief Executive Officer | 28 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Tommy Thompson | 57 |
| Ernest Mario | 44 |
| Mahendra Shah | 34 |
| Elizabeth Czerepak | 31 |
| Brent Ahrens | 30 |
| Edgar Engleman | 29 |
| David Lemus | 22 |
| Henry Ji | 17 |
| Jaisim Shah | 17 |
| Yue Wu | 16 |
| Laura Hamill | 15 |
| Suketu D. Desai | 14 |
| Daniel J. Estes | 13 |
| Suresh K. Khemani | 12 |
| David J. Wustrow | 9 |
- Bolsa de valores
- Insiders
- Dmitri V. Lissin
- Conexiones Empresas
